Literature DB >> 21235663

Congestive heart failure after extensive catheter ablation for atrial fibrillation: prevalence, characterization, and outcome.

Hong-Wei Tan1, Xin-Hua Wang, Hai-Feng Shi, Yu-Ming Sun, Li Zhou, Jia-Ning Gu, Bing Han, Wei-Feng Jiang, Guo-Shu Yang, Xu Liu.   

Abstract

INTRODUCTION: This study sought to describe a new complication of catheter ablation for atrial fibrillation (AF): new onset congestive heart failure (CHF) after extensive ablation for AF. METHODS AND
RESULTS: Data from 12 patients developing CHF after ablation were prospectively collected. All patients underwent extensive ablation for AF including circumferential pulmonary venous ablation and complex fractionated atrial electrograms guided ablation. CHF was diagnosed using the following criteria: symptoms or signs of heart failure, elevated BNP, and echocardiographic evidence of left ventricular diastolic dysfunction. Twelve patients (5 persistent and 7 permanent AF) had CHF after extensive ablation out of 484 consecutive AF patients who underwent catheter ablation (prevalence 2.5%). None of these 12 patients had CHF prior to the procedure. The mean onset of the symptoms was 39 ± 14 hours after the index procedure. Dyspnea and pulmonary rales were the most observed symptoms or signs. White blood cell count, serum CRP, BNP, and echocardiographic parameters of left ventricular diastolic dysfunction (E/A, E/E') were significantly increased after the onset of symptoms. All patients had complete recovery with supportive therapy within 3 days of the onset of symptoms.
CONCLUSIONS: In this single-center experience, CHF after extensive ablation for AF was a well-recognized complication with a relatively high incidence of 2.5%. Measurement of BNP, CRP, and E/A, E/E' is useful in managing these patients.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21235663     DOI: 10.1111/j.1540-8167.2010.01980.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  Why atrial fibrillation recurs in patients who obtained current ablation endpoints with longstanding persistent atrial fibrillation.

Authors:  Liang Zhao; Weifeng Jiang; Li Zhou; Jun Gu; Yuanlong Wang; Yugang Liu; Xiaodong Zhang; Shaohui Wu; Xu Liu
Journal:  J Interv Card Electrophysiol       Date:  2013-07-06       Impact factor: 1.900

2.  Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.

Authors:  Aditya J Ullal; Daniel W Kaiser; Jun Fan; Susan K Schmitt; Claire T Than; Wolfgang C Winkelmayer; Paul A Heidenreich; Jonathan P Piccini; Marco V Perez; Paul J Wang; Mintu P Turakhia
Journal:  J Cardiovasc Electrophysiol       Date:  2016-12-05

3.  Impact of Chronic Obstructive Pulmonary Disease on Atrial Fibrillation Ablation Outcomes According to the National Readmission Database.

Authors:  Ahmed M Maraey; Muhammad Haisum Maqsood; Mahmoud Khalil; Ahmed Hashim; Ahmed M Elzanaty; Hadeer R Elsharnoby; Eman Elsheikh; Lamiaa Elbatanony; Kenneth Ong; Paul Chacko
Journal:  J Innov Card Rhythm Manag       Date:  2022-08-15

4.  Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study.

Authors:  Shilpkumar Arora; Sopan Lahewala; Byomesh Tripathi; Varshil Mehta; Varun Kumar; Divya Chandramohan; Alejandro Lemor; Mihir Dave; Nileshkumar Patel; Nilay V Patel; Ghanshyam Palamaner Subash Shantha; Juan Viles-Gonzalez; Abhishek Deshmukh
Journal:  J Am Heart Assoc       Date:  2018-06-15       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.